Muscarinic receptor agonists, compositions, methods of treatment thereof, and processes for preparation thereof

Details for Australian Patent Application No. 2009220270 (hide)

Owner AstraZeneca AB

Inventors Jin, Shujuan; Tomaszewski, Miroslaw Jerzy; Santhakumar, Vijayaratnam

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009220270

PCT Pub. Number WO2009/110844

Priority 61/033,082 03.03.08 US

Filing date 2 March 2009

Wipo publication date 11 September 2009

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/454 (2006.01)

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

23 September 2010 PCT application entered the National Phase

  PCT publication WO2009/110844 Priority application(s): WO2009/110844

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009220289-Environmentally friendly device for slowing global warming, also known as an emission purifying system

2009220251-A lamination station for laminating a paperboard or cardboard web